{"id":"https://openalex.org/W2946955088","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.9109","title":"Viagenpumatucel-L (HS-110) plus nivolumab in patients with advanced non-small cell lung cancer (NSCLC) after checkpoint inhibitor treatment failure.","display_name":"Viagenpumatucel-L (HS-110) plus nivolumab in patients with advanced non-small cell lung cancer (NSCLC) after checkpoint inhibitor treatment failure.","publication_year":2019,"publication_date":"2019-05-20","ids":{"openalex":"https://openalex.org/W2946955088","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.9109","mag":"2946955088"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2019.37.15_suppl.9109","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.9109","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.9109","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031420337","display_name":"Daniel Morgensztern","orcid":"https://orcid.org/0000-0003-4349-2028","observed_orcids":["https://orcid.org/0000-0003-4349-2028"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Morgensztern","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005462156","display_name":"Rachel E. Sanborn","orcid":"https://orcid.org/0000-0003-0542-6054","observed_orcids":["https://orcid.org/0000-0003-0542-6054"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel E. Sanborn","raw_affiliation_strings":["Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR;","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036466135","display_name":"Lyudmila A. Bazhenova","orcid":"https://orcid.org/0000-0001-8764-4359","observed_orcids":["https://orcid.org/0000-0001-8764-4359"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lyudmila Bazhenova","raw_affiliation_strings":["University of California, San Diego, La Jolla, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, La Jolla, CA;","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080011474","display_name":"Saiama Naheed Waqar","orcid":"https://orcid.org/0000-0002-7069-5456","observed_orcids":["https://orcid.org/0000-0002-7069-5456"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saiama Naheed Waqar","raw_affiliation_strings":["Washington University School of Medicine, St. Louis, MO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, St. Louis, MO;","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070377221","display_name":"Lori McDermott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158068","display_name":"Heat Biologics (United States)","ror":"https://ror.org/05p6m4w34","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158068"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lori McDermott","raw_affiliation_strings":["Heat Biologics, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heat Biologics, Durham, NC;","institution_ids":["https://openalex.org/I4210158068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111821064","display_name":"Jeff T. Hutchins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158068","display_name":"Heat Biologics (United States)","ror":"https://ror.org/05p6m4w34","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158068"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff Hutchins","raw_affiliation_strings":["Heat Biologics, Inc., Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heat Biologics, Inc., Durham, NC;","institution_ids":["https://openalex.org/I4210158068"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027326018","display_name":"David L. Rimm","orcid":"https://orcid.org/0000-0001-5820-4397","observed_orcids":["https://orcid.org/0000-0001-5820-4397"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David L. Rimm","raw_affiliation_strings":["Yale School of Medicine, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale School of Medicine, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012572593","display_name":"Luis Estuardo Raez","orcid":"https://orcid.org/0000-0003-2669-5771","observed_orcids":["https://orcid.org/0000-0003-2669-5771"]},"institutions":[{"id":"https://openalex.org/I19700959","display_name":"Florida International University","ror":"https://ror.org/02gz6gg07","country_code":"US","type":"education","lineage":["https://openalex.org/I19700959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luis E. Raez","raw_affiliation_strings":["Memorial Cancer Institute, Florida International University, Miami, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Cancer Institute, Florida International University, Miami, FL;","institution_ids":["https://openalex.org/I19700959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090256464","display_name":"Corey Jay Langer","orcid":"https://orcid.org/0000-0002-8483-6811","observed_orcids":["https://orcid.org/0000-0002-8483-6811"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey J. Langer","raw_affiliation_strings":["University of Pennsylvania Perelman School of Medicine, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110382646","display_name":"Roger B. Cohen","orcid":"https://orcid.org/0009-0004-7423-2653","observed_orcids":["https://orcid.org/0009-0004-7423-2653"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger B. Cohen","raw_affiliation_strings":["University of Pennsylvania Perelman School of Medicine, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania Perelman School of Medicine, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"15_suppl","first_page":"9109","last_page":"9109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0333000011742115,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8600000143051147},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/anti-pd-1-resistance","display_name":"anti-PD-1 resistance","score":0.6259999871253967},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7250000238418579},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9039999842643738},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.6830000281333923},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5519999861717224},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6359999775886536},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.906000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8943262100219727},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7327162623405457},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.572495698928833},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5596242547035217},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4715820848941803},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4658981263637543},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.453986793756485},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43812376260757446},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3528949022293091},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.32103434205055237},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31025606393814087},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.30841296911239624}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2019.37.15_suppl.9109","doi":"https://doi.org/10.1200/jco.2019.37.15_suppl.9109","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2019.37.15_suppl.9109","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2962424696","https://openalex.org/W3013183348","https://openalex.org/W3173117517","https://openalex.org/W2780265289","https://openalex.org/W3028682949","https://openalex.org/W2568340991","https://openalex.org/W2599974056","https://openalex.org/W1971718789","https://openalex.org/W3089032599","https://openalex.org/W4381162606"],"abstract_inverted_index":{"9109":[0],"Background:":[1],"Viagenpumatucel-L":[2],"(HS-110)":[3],"is":[4,37,332],"an":[5,26],"allogeneic":[6],"cellular":[7],"vaccine":[8],"derived":[9],"from":[10],"a":[11,38,69,78,239],"human":[12],"lung":[13],"adenocarcinoma":[14],"cell":[15,34],"line":[16,193],"transfected":[17],"with":[18,52,63,77,92,238,273],"the":[19,42,149,165,348],"gp96-Ig":[20],"fusion":[21],"protein":[22],"that":[23,347],"functions":[24],"as":[25,143,189],"antigen":[27],"chaperone":[28],"for":[29,104,126],"cross":[30],"presentation":[31],"and":[32,46,108,134,182,184,214,281,312,316,330,343],"dendritic":[33],"activation.":[35],"DURGA":[36],"multi-cohort":[39],"study":[40,87],"evaluating":[41],"combination":[43,327],"of":[44,61,71,74,164,194,243,297,328,350],"HS-110":[45,329,351],"anti-PD-1":[47],"monoclonal":[48],"antibodies":[49],"in":[50,148,340],"patients":[51,62,272],"advanced":[53],"NSCLC.":[54],"We":[55],"report":[56],"on":[57,360],"Cohort":[58],"B,":[59],"consisting":[60],"progressive":[64],"disease":[65],"(PD)":[66],"after":[67,179,357],"receiving":[68],"minimum":[70],"4":[72],"months":[73,231],"treatment":[75],"(tx)":[76],"checkpoint":[79],"inhibitor":[80],"(CPI)":[81],"at":[82,124,290],"any":[83],"time":[84],"prior":[85,199,361],"to":[86,206,266,337,352],"entry.":[88],"Methods:":[89],"Patients":[90],"(pts)":[91],"previously":[93],"treated":[94],"NSCLC":[95],"received":[96],"weekly":[97],"HS0110":[98],"(1":[99],"X":[100],"107":[101],"cells)":[102],"intradermally":[103],"18":[105,174],"consecutive":[106],"weeks":[107,115],"nivolumab":[109,331,353],"IV":[110],"240":[111],"mg":[112],"every":[113],"2":[114,203,276],"until":[116],"intolerable":[117],"toxicity":[118],"or":[119,131,302],"PD.":[120],"Tissue":[121],"was":[122,141,155,202,224,229,283],"tested":[123],"baseline":[125],"PD-L1":[127],"expression":[128],"(\u2265":[129],"1%":[130],"<":[132],"1%)":[133],"tumor":[135,150,358],"infiltrating":[136],"lymphocytes":[137,147],"(TILs).":[138],"TIL":[139,278,284],"high":[140],"defined":[142],">":[144],"10%":[145],"CD8+":[146],"stroma.":[151],"The":[152,196,304,326],"primary":[153],"endpoint":[154],"objective":[156],"response":[157,213],"rate":[158,223],"by":[159],"RECIST":[160],"1.1.":[161],"Results:":[162],"As":[163],"September":[166],"2018":[167],"data":[168,345],"cut-off,":[169],"20":[170],"pts":[171,175,209,216,288],"were":[172,277,299,308,320],"enrolled.":[173],"(90%)":[176],"had":[177,187,218,252],"PD":[178],"both":[180],"chemotherapy":[181],"CPI,":[183],"14":[185],"(70%)":[186],"CPI":[188,362],"their":[190],"most":[191,305],"recent":[192],"tx.":[195],"median":[197,240],"number":[198],"tx":[200],"lines":[201],"[range":[204],"1":[205,301],"6].":[207],"3":[208,271],"(15%)":[210],"achieved":[211],"partial":[212],"8":[215],"(40%)":[217],"stable":[219],"disease.":[220],"Disease":[221],"control":[222],"55%.":[225],"Progression-free":[226],"survival":[227],"(PFS)":[228],"2.7":[230],"(95%":[232],"CI,":[233],"1.8":[234],"\u2013":[235],"4.0":[236],"months)":[237],"follow":[241],"up":[242],"6":[244],"months.":[245],"Pts":[246,335],"experiencing":[247],"injection":[248],"site":[249],"reactions":[250],"(ISR)":[251],"improved":[253],"PFS":[254],"(median":[255],"NR":[256],"vs":[257],"2.2":[258],"months;":[259],"HR":[260],"0.23,":[261],"p":[262],"=":[263],"0.063)":[264],"compared":[265],"those":[267],"without":[268],"ISR.":[269],"Of":[270],"confirmed":[274],"response,":[275],"low/PD-L1":[279],"positive,":[280],"one":[282,292],"high/PD-L1":[285],"negative.":[286],"All":[287],"experienced":[289],"least":[291],"adverse":[293],"event":[294],"(AE),":[295],"80%":[296],"which":[298],"grade":[300,322],"2.":[303],"common":[306],"AEs":[307],"fatigue":[309],"(42%),":[310],"cough":[311],"dyspnea":[313],"(22.6%":[314],"each)":[315],"anemia":[317],"(16.1%).":[318],"There":[319],"no":[321],"5":[323],"AEs.":[324],"Conclusions:":[325],"well":[333],"tolerated.":[334],"continue":[336],"be":[338],"enrolled":[339],"this":[341],"cohort":[342],"early":[344],"suggest":[346],"addition":[349],"may":[354],"restore":[355],"responsiveness":[356],"progression":[359],"therapy.":[363],"Clinical":[364],"trial":[365],"information:":[366],"NCT02439450.":[367]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":4}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2019-06-07T00:00:00"}